Bethanne Snodgrass, MD in Sylvania, OH - Plastic Surgery

Bethanne Snodgrass, MD is a Plastic Surgery physician based in Sylvania, Ohio. Bethanne Snodgrass is licensed to practice in Ohio (license number 35050368) and her current practice location is 5300 Harroun Rd, Suite 216, Sylvania, Ohio. She can be reached at her office (for appointments etc.) via phone at (419) 885-4544.

NPI number for Bethanne Snodgrass is 1881691897 and her current mailing address is 4235 Secor Rd, Toledo, Ohio. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1881691897.

Contact Information

	Bethanne Snodgrass, MD
	5300 Harroun Rd, Suite 216, Sylvania, OH 43560-2182
	(419) 885-4544
	Not Available

Physician's Profile

Full Name	Bethanne Snodgrass
Gender	Female
Speciality	Plastic Surgery
Location	5300 Harroun Rd, Sylvania, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1881691897
Provider Enumeration Date: 07/05/2005
Last Update Date: 05/25/2011

Medical Identifiers

Medical identifiers for Bethanne Snodgrass such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881691897	NPI	-	NPPES
0627889	Medicaid	OH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208200000X	Plastic Surgery	35050368 (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bethanne Snodgrass is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bethanne Snodgrass, MD 4235 Secor Rd, Toledo, OH 43623-4231 Ph: (419) 885-4544	Bethanne Snodgrass, MD 5300 Harroun Rd, Suite 216, Sylvania, OH 43560-2182 Ph: (419) 885-4544

News Archive

Preliminary Phase 3 clinical study results of T-Pred released

ISTA Pharmaceuticals, Inc., today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). The Company is developing T-Pred as a treatment for inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection exists, or there is a risk of bacterial infection.

With Adderall shortage, drug counterfeiters try to seize a market opportunity

A shortage of Adderall began last year, sending millions of people with attention deficit/hyperactivity disorder and narcolepsy on perpetual wild goose chases to find drugstores with the pills they need to stay alert and focused. So it's not surprising that Adderall counterfeiters have seized a big marketing opportunity. What is surprising is their clumsiness.

Massive majority of doctors against pension changes

Doctors could leave the NHS in droves if controversial proposals to raise the retirement age go ahead.

Scientists discover new mechanism of drug resistance in hospital microbes

Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to approximately 100,000 deaths and more than $30 billion in additional health care costs yearly.

Bethanne Snodgrass, MD - Plastic Surgery in Sylvania, OH